Share on StockTwits

Ovascience (NASDAQ:OVAS)‘s stock had its “buy” rating reiterated by Wedbush in a research note issued on Tuesday.

Shares of Ovascience (NASDAQ:OVAS) traded up 1.62% during mid-day trading on Tuesday, hitting $12.52. The stock had a trading volume of 10,584 shares. Ovascience has a 52-week low of $5.509 and a 52-week high of $14.44. The stock’s 50-day moving average is $10.20 and its 200-day moving average is $9.10. The company’s market cap is $295.4 million.

Ovascience (NASDAQ:OVAS) last released its earnings data on Thursday, August 7th. The company reported ($0.42) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.45) by $0.03. Analysts expect that Ovascience will post $-1.83 EPS for the current fiscal year.

OvaScience, Inc, is a life science company developing products to improve the treatment of female infertility based on recent scientific discoveries about the existence of egg precursor cells.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.